Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on COV, GALE, YRCW and YY Issued by the Bedford Report

YELLQ, YY
Free Research Reports on COV, GALE, YRCW and YY Issued by the Bedford Report
http://media.marketwire.com/attachments/201211/53317_equitynewscircuit-logo-final.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1014477&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwired) -- 05/07/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Covidien plc (NYSE: COV) shares have increased approximately 13.0 percent year-to-date. The company now estimates that net sales for the second quarter of fiscal 2013 to grow 4 percent to 5 percent, reflecting the planned spin-off of their Pharmaceuticals business, which is expected to be completed on June 28, 2013.

Find out more about Covidien including full access to the free equity report at: www.BedfordReport.com/COV

Galena Biopharma Inc. (NASDAQ: GALE) shares spiked 11.69 percent on volume of nearly 3.5 million shares traded Monday to close at $2.77 a share. The company has recently named William L. Ashton to its Board of Directors. Mr. Ashton was previously Vice President of corporate and government affairs and Vice President of sales at Amgen.

Find out more about Galena Biopharma including full access to the free equity report at: www.BedfordReport.com/GALE

YRC Worldwide, Inc. (NASDAQ: YRCW) shares soared 41.0 percent on volume of 2.59 million shares traded to close at $15.44 a share. The company was one of the biggest movers on the market Monday as it reported a narrower loss for the first quarter of 2013. BB&T Capital Markets have recently upgraded YRC's rating to "hold" from "underweight".

Find out more about YRC Worldwide including full access to the free equity report at: www.BedfordReport.com/YRCW

YY Inc. (NASDAQ: YY) shares gained 20.11 percent on volume of over 1.0 million shares traded Monday to close at $21.98. The Chinese social platform reported net income grew to RMB63.9 million (US$10.3 million) in the first quarter of 2013, compared to just RMB3.5 million in the year ago quarter.

Find out more about YY including full access to the free equity report at: www.BedfordReport.com/YY

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today